BDBM585236 (E)-2-(2-(2-(4-((4-((6-chloro-2-methyl-2H-indazol-5-yl)imino)-2,6-Dioxy-3-(2,4,5-trifluorobenzyl)-1,3,5-triazin-1-yl)methyl)-1H-1,2,3-triazol-1-yl)ethoxy)ethoxy)-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoquinolin-4-yl)acetamide::US11530195, Compound 17

SMILES Cn1cc2cc(\N=c3/[nH]c(=O)n(Cc4cn(CCOCCOCC(=O)Nc5cccc6C(=O)N(C7CCC(=O)NC7=O)C(=O)c56)nn4)c(=O)n3Cc3cc(F)c(F)cc3F)c(Cl)cc2n1

InChI Key

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 585236   

TargetReplicase polyprotein 1ab(2019-nCoV)
Shaanxi Panlong Pharmaceutical

US Patent
LigandPNGBDBM585236((E)-2-(2-(2-(4-((4-((6-chloro-2-methyl-2H-indazol-...)
Affinity DataIC50: <100nMAssay Description:The inhibitory activity of the compounds against SARS-CoV-2 3CLpro was determined using fluorescence resonance energy transfer.10 μL of the comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent